Rochester, MNNCT06940037Now EnrollingIRB Ready

Aging Clinical Trial in Rochester, MN

Access cutting-edge aging treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions…

Expert Care in Rochester

Access aging specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related aging treatment provided free

Apply for This Rochester Location

Check if you qualify for this aging clinical trial in Rochester, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Aging Study in Rochester

To critically examine biological, clinical, and behavioral modulators of progressive resistance training-associated exercise response heterogeneity in physical function and whole-body metabolism in older adults.

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

aged greater than or equal to 65 years
sedentary (Community Healthy Activities Model Program for Seniors physical activity questionnaire to identify and exclude persons engaged in regular (125 min/week or more) moderate intensity physical activity
at risk for mobility disability score of less than or equal to 10 (but greater than 3) on the SPPB
willing to be randomized into HE or PRT
willing to be transported or transport themselves to the clinical sites for the intervention and assessments

Exclusion Criteria

unwillingness to provide informed consent
participation in lifestyle or pharmacologic intervention trial or structured program of exercise training in the past 6 months
an SPPB score of less than or equal to 3
osteoarthritis or condition with joint pain limiting daily life activities
significant weight loss or gain (7.5% of body weight) in past six months
current anti-coagulant or anti-platelet therapy (Coumadin, Eliquis, Pradaxa, Xarelto, heparin, Lovenox, Plavix)
clinically significant abnormality in any of the screening laboratory values, including those identified as outside of the "normal limits', that are deemed to be of concern for participation in the study by the study physician
acute or terminal illness
Mini Mental State Exam (MMSE) \<23
myocardial infarction in the previous 6 months or other symptomatic coronary artery disease
New York Heart Association Class III or IV congestive heart failure
serious conduction disorder (e.g., 3rd degree heart block), uncontrolled arrhythmia, or new Q waves or ST-segment depressions (\>3 mm) on ECG
chronic obstructive pulmonary disease requiring oxygen therapy
upper or lower extremity fracture in the previous 6 months
uncontrolled hypertension (150/90 mm Hg)
neuromuscular diseases and/or drugs which affect neuromuscular function
current use of anabolic steroids, growth hormone, replacement androgen therapy, anti-androgen therapy
allergy to lidocaine
presence of significant liver or renal disease (eGFR \< 45 mL/min)
diagnosis of type I diabetes mellitus or insulin requiring type 2 diabetes mellitus
HbA1c \> 7%
BMI \<21 or \>35 for men or \>40 for women
excessive alcohol intake (\>14 alcoholic beverages per wk.)
current tobacco use
current participation in any interventional clinical trial
current use of weight loss medications

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT06940037) has an active research site in Rochester, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Aging Treatment Options in Rochester, MN

If you're searching for aging treatment options in Rochester, MN, this clinical trial (NCT06940037) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced aging specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all aging clinical trials near you to find additional studies recruiting in your area.

More Progeria Trials in Rochester, MN

See all progeria clinical trials recruiting in Rochester — not just this study.

Browse Progeria Trials in Rochester →

Browse More Trials by Condition

Progeria TrialsAll Conditions →

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, MN